|
|
Post by suebeeee1 on Oct 27, 2014 12:56:05 GMT -5
With earnings expected next Monday, November 3rd and a conference call on our immediate horizons, what are your expectations?
|
|
|
|
Post by bighaus89 on Oct 27, 2014 13:27:49 GMT -5
For earnings, the 150m added to the balance sheet. For the conference call, I don't expect much except that production of Afrezza is in full swing and Sanofi will begin marketing in November.
|
|
|
|
Post by kc on Oct 27, 2014 16:26:08 GMT -5
It will not be a positive number as there are no real earnings yet. Not sure the impact of the partnership payment. |
|
|
|
Post by papihoyos on Oct 27, 2014 18:30:34 GMT -5
I don't care about earning.
I want to know about production, production and more production, cash balances and quarterly G & A burn rate. Also want to know about pipeline of new products.
As for sales prediction, you aré not going to get that from mnkd.
|
|
|
|
Post by bighaus89 on Oct 27, 2014 18:46:23 GMT -5
I don't care about earning. I want to know about production, production and more production, cash balances and quarterly G & A burn rate. Also want to know about pipeline of new products. As for sales prediction, you aré not going to get that from mnkd. Agreed. If Sanofi does not say anything during their earnings call about MNKD tomorrow, MNKD will be saying only what Sanofi will allow them to on Nov. 3rd. |
|
|
|
Post by papihoyos on Oct 27, 2014 22:46:16 GMT -5
I don't care about earning. I want to know about production, production and more production, cash balances and quarterly G & A burn rate. Also want to know about pipeline of new products. As for sales prediction, you aré not going to get that from mnkd. Agreed. If Sanofi does not say anything during their earnings call about MNKD tomorrow, MNKD will be saying only what Sanofi will allow them to on Nov. 3rd. You can get sales forecast from production, hopefully mnkd can at least speak to that. |
|
